August 27, 2016 4:01 AM ET

Biotechnology

Company Overview of ZyStor Therapeutics, Inc.

Company Overview

ZyStor Therapeutics, Inc. develops therapeutics for patients with genetic disorders. The company offers enzyme replacement therapies for the treatment of lysosomal storage diseases. The company was formerly known as Symbiontics, Inc. ZyStor Therapeutics, Inc. was incorporated in 2004 and is based in Milwaukee, Wisconsin. As of August 17, 2010, ZyStor Therapeutics, Inc. operates as a subsidiary of BioMarin Pharmaceutical Inc.

10437 Innovation Drive

Suite 100

Milwaukee, WI 53226-4838

United States

Founded in 2004

Phone:

414-727-9777

Fax:

414-727-9727

Key Executives for ZyStor Therapeutics, Inc.

Chief Executive Officer, President and Director
Chief Scientific Officer and Executive Vice President
Chief Scientist and Chairman of Scientific Advisory Board
Compensation as of Fiscal Year 2016.

Similar Private Companies By Industry

Company Name Region
20n Labs, Inc. United States
23andMe, Inc. United States
2C Tech Corporation, Inc. United States
3-V Biosciences, Inc. United States
3D Bio Holdings LLC United States

Recent Private Companies Transactions

Type
Date
Target
No transactions available in the past 12 months.
 

The information and data displayed in this profile are created and managed by Capital IQ, a Standard & Poor's company. Bloomberg.com does not create or control the content. For inquiries, please contact Capital IQ directly by clicking here.

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup

Most Searched Private Companies

Company Name Geographic Region
Lawyers Committee for Civil Rights Under Law United States
Bertelsmann AG Europe
Bloomberg L.P. United States
NYC2012, Inc. United States
Rush University United States

Sponsored Financial Commentaries

Sponsored Links

Request Profile Update

Only a company representative may request an update for the company profile. Documentation will be required.

To contact ZyStor Therapeutics, Inc., please visit --. Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.